Journal article · 2022 · Open access

Pharmacogenomics: an opportunity for safer and efficient pharmacotherapy

Guilherme Carneiro Montes, Graziele Freitas de Bem, Fabrícia Lima Fontes-Dantas

Research Society and Development, 11(17), e44111738884 · Published 19 December 2022 · DOI 10.33448/rsd-v11i17.38884

Open PDFView at the publisherCite this paper

In brief

“Pharmacogenomics: an opportunity for safer and efficient pharmacotherapy” is a 2022 journal article by Guilherme Carneiro Montes and 2 co-authors, published in Research Society and Development. OpenAlex counts 1 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at Research Society and Development.

Citations
1
Most cited in
2025 (1)
Field-weighted impact
0.13
References
89
Authors
3

Abstract

Responses to drugs are influenced by multiple factors, including health status, environmental influences, and genetic characteristics. The bioavailability of a drug can vary widely among individuals with a similar weight under the same drug dosage, which might result in toxicity and adverse drug reactions (ADRs). Genetic polymorphisms are known causes of interindividual differences in disease risk and treatment response in humans. In fact, a relevant number of associations between human genetic variants and predisposition to adverse events were described for diverse kinds of drug interactions, involving hundreds of proteins like receptors, transporters, and metabolizing enzymes. In this way, Pharmacogenetics and Pharmacogenomics emerged aiming to determine the genetic component responsible for drug response. A particular attention is showed if a treatment benefits (or harms) a particular subgroup, considering the interaction between treatment and genetic background. In this scenario, researchers have focused on better understanding personalized medicine, which holds the potential to maximize drug efficiency and minimize toxic effects. This review aims to introduce some principles, perspectives, and clinical applications of pharmacogenetics, emphasizing important findings and clinical applications that may contribute to therapeutical improvement.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Montes, G. C., de Bem, G. F., & Fontes-Dantas, F. L. (2022). Pharmacogenomics: an opportunity for safer and efficient pharmacotherapy. Research Society and Development, 11(17), e44111738884. https://doi.org/10.33448/rsd-v11i17.38884

MLA 9

Montes, Guilherme Carneiro, et al. “Pharmacogenomics: an opportunity for safer and efficient pharmacotherapy.” Research Society and Development, vol. 11, no. 17, 2022, p. e44111738884. https://doi.org/10.33448/rsd-v11i17.38884.

Chicago

Montes, Guilherme Carneiro, Graziele Freitas de Bem, and Fabrícia Lima Fontes-Dantas. 2022. “Pharmacogenomics: an opportunity for safer and efficient pharmacotherapy.” Research Society and Development 11 (17): e44111738884. https://doi.org/10.33448/rsd-v11i17.38884.

Harvard

Montes, G. C., de Bem, G. F. and Fontes-Dantas, F. L. (2022) ‘Pharmacogenomics: an opportunity for safer and efficient pharmacotherapy’, Research Society and Development, 11(17), p. e44111738884. doi:10.33448/rsd-v11i17.38884.

IEEE

G. C. Montes, G. F. de Bem, and F. L. Fontes-Dantas, “Pharmacogenomics: an opportunity for safer and efficient pharmacotherapy,” Research Society and Development, vol. 11, no. 17, p. e44111738884, 2022, doi: 10.33448/rsd-v11i17.38884.

BibTeX

@article{montes2022pharmacogenomics,
  title     = {{Pharmacogenomics: an opportunity for safer and efficient pharmacotherapy}},
  author    = {Montes, Guilherme Carneiro and de Bem, Graziele Freitas and Fontes-Dantas, Fabrícia Lima},
  journal   = {Research Society and Development},
  year      = {2022},
  volume    = {11},
  number    = {17},
  pages     = {e44111738884},
  doi       = {10.33448/rsd-v11i17.38884},
  url       = {https://doi.org/10.33448/rsd-v11i17.38884}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism

  • pharmacogenomics
  • pharmacogenetics
  • personalized medicine
  • genetic polymorphism
  • adverse drug reactions
  • drug metabolism
  • drug transporters
  • drug receptors

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Montes, G. C., de Bem, G. F., & Fontes-Dantas, F. L. (2022). Pharmacogenomics: an opportunity for safer and efficient pharmacotherapy. Research Society and Development, 11(17), e44111738884. https://doi.org/10.33448/rsd-v11i17.38884

How many times has this paper been cited?

1 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Research Society and Development: sign in and open the PDF from this page.

Who wrote this paper?

Guilherme Carneiro Montes, Graziele Freitas de Bem, Fabrícia Lima Fontes-Dantas.

What is the DOI of this paper?

10.33448/rsd-v11i17.38884, permanently at https://doi.org/10.33448/rsd-v11i17.38884. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.